Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor functionErwan Bézard, Pierre Sokoloff, Sandrine Ferry et al.|Nature Medicine|2003Cited by 381
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptorsC. Guigoni, Erwan Bézard, L. Leriche et al.|Parkinsonism & Related Disorders|2005Cited by 134
<i>N</i>-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D<sub>2</sub> and D<sub>3</sub> Receptor LigandsAnneke E. Hackling, Holger Stark, Robin Ghosh et al.|Journal of Medicinal Chemistry|2003Cited by 104
Lack of association between schizophrenia and alleles of the dopamine D1, D2, D3 and D4 receptor loci1Markus M. Nöthen, Brian F. O’Dowd, Lars Lannfelt et al.|Psychiatric Genetics|1993Cited by 43
Dopamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology DatabaseJean‐Martin Beaulieu, Hubert H.M. Van Tol, Emiliana Borrelli et al.|IUPHAR/BPS Guide to Pharmacology CITE|2019Cited by 10